Research Projects & Grants

For Profit Organization

  • A randomized double-blind parallel study of rabeprazole extended-release 50 mg versus esomeprazole 40 mg for healing and symptomatic relief of moderate to severe erosive gastroesophageal reflux disease (GERD), Role: Investigator, Eisai Medical Research, Inc., (02/2009 - 02/2010) Status: Completed
  • A multicenter, randomized, placebo-controlled, doubleblinded study of the efficacy and safety of lubiprostone in patients with opioid-induced bowel dysfuction, Role: Investigator, Sucampo Pharmaceuticals, Inc., (01/2009 - 01/2010) Status: Completed
  • Intron A plus ribavirin therapy for patients with chronic hepatitis C who have failed previous interferon treatment, Role: Investigator, Schering Plough, (02/2000 - 02/2001) Status: Completed
  • A multicenter, open-label, long term safety study of H 199/18 40 mg in subjects with healed erosive esophagitis, Role: Investigator, ASTRA (USA), (10/1998 - 10/1999) Status: Completed
  • A twelve-week randomized, double blind, placebo-controlled, multi-center study of alosetron in female subjects with irritable bowel syndrome - phase III, Role: Investigator, Glaxo Wellcome Foundation, (08/1998 - 08/1999) Status: Completed
  • A multicenter, randomized, double blind, eight week comparative efficacy and safety study of H199/18 20 mg and omeprazole 20 mg in study subjects with erosive esophagitis, Role: Investigator, ASTRA (USA), (10/1997 - 10/1998) Status: Completed
  • Controlled trial of reversal of Barrett's Esophagus with acid suppression and multi-polar electrocoagulation, Role: Investigator, TAP Pharmaceuticals, Inc,, (07/1997 - 07/1998) Status: Completed
  • A Study to Evaluate the Effects of Therapy with Lansoprazole and Clarithromycin and/or Amoxicillin on the Eradication of Helicobacter Pylori, Role: Investigator, TAP Pharmaceuticals, Inc,, (08/1995 - 08/1996) Status: Completed

Internal

  • Endoscopic drainage of pancreatic fluid collections using a self-expandable metal stent: a single-center experience, Role: PI, LLU Dept. of Gastroenterology, (02/2012 - 02/2013) Status: Completed
  • Vitamin D in Vivo Pilot Study, Role: Principal Investigator, LLU Dept. of Gastroenterology, (02/2009 - 05/2011) Status: Closed
  • GI Fellowship, Role: Principal Investigator, LLU Dept. of Gastroenterology, (01/2007 - 12/2014) Status: Closed
  • Comparison of endoscopic sphincter dilation vs. sphincterotomy for the extraction of bile duct stones: a randomized, prospective study, Role: Investigator, LLU Dept. of Medicine, (02/1999 - 02/2000) Status: Completed
  • Factors influencing the natural history of bleeding peptic ulcers, Role: Investigator, LLU Dept. of Medicine, (07/1998 - 07/1999) Status: Completed
  • Clarithromycin, amoxicillin, and omeprazole or placebo for the treatment of patients with dyspepsia and Helicobacter pylori infection, Role: Investigator, LLU Dept. of Medicine, (05/1997 - 05/1998) Status: Completed
  • Electrogastrography to Measure Gastric Myoelectric Activity in Healthy Term and Preterm Infants, Role: Investigator, LLU GI Research Fund, (02/1995 - 02/1996) Status: Completed

Non-Profit Organization

  • Effect of Growth Factors on Vitamin D3 in Intestinal Epithelia Cells in Comparison to Asacol, Role: Principal Investigator, Embryon, (10/2007 - 06/2009) Status: Closed